Decline in acute upper gastrointestinal bleeding during COVID-19 pandemic after initiation of lockdown in Austria

Andreas Schmiderer1, Hubert Schwaighofer1, Lukas Niederreiter1

  • 1Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University Innsbruck, Innsbruck, Austria.

Endoscopy
|May 15, 2020
PubMed

Insights

The COVID-19 lockdown in Austria led to a significant 40.7% reduction in acute upper gastrointestinal (GI) bleeding cases. Nonvariceal bleeding events saw a notable decline, while variceal hemorrhage rates remained stable.

Area of Science:

  • Gastroenterology
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic necessitated widespread public health interventions, including national lockdowns.
  • Austria implemented a national lockdown on March 16, 2020, to curb the spread of COVID-19.
  • The impact of such lockdowns on acute medical conditions, specifically upper gastrointestinal bleeding, was not well-understood.

Purpose of the Study:

  • To investigate the effect of the national COVID-19 lockdown on the incidence of acute upper gastrointestinal (GI) bleeding in Austria.
  • To analyze changes in the frequency of specific types of upper GI bleeding, namely variceal and nonvariceal, before and after the lockdown.

Main Methods:

  • A retrospective study involving 98 Austrian hospitals performing emergency endoscopies.
  • Data collection focused on upper GI endoscopies for hematemesis or melena with visible bleeding signs.
  • The study compared data from the three weeks preceding the lockdown (Week 9) with the three weeks following its initiation (Week 14).

Main Results:

  • A 40.7% reduction in total upper GI bleeding events was observed post-lockdown (341 cases) compared to pre-lockdown (575 cases).
  • Nonvariceal bleeding events decreased by 54.6% after the lockdown compared to the pre-lockdown period.
  • Rates of variceal hemorrhage showed no significant change between the pre-lockdown and post-lockdown periods.

Conclusions:

  • The national lockdown in Austria was associated with a substantial decrease in acute upper GI bleeding events.
  • The reduction was primarily driven by a decline in nonvariceal bleeding cases.
  • These findings highlight the significant impact of public health measures on healthcare utilization for conditions like upper GI bleeding.
Abstract

Related Concept Videos

Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
294
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
660
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.0K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
954
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
448